![](https://www.sermo.com/wp-content/uploads/2024/04/sentiment-study-14-720x405.jpg)
Part 14
HCP perspectives on artificial intelligence (AI) in a data-driven world
![](https://www.sermo.com/wp-content/uploads/2023/11/sentiment-study-13-720x405.jpg)
Part 13
How to: Optimize your HCP social media strategy
![](https://www.sermo.com/wp-content/uploads/2023/06/sentiment-study-12-720x405.jpg)
Part 12
Social media impact, medical congresses & the patient dynamic among oncologists
![](https://www.sermo.com/wp-content/uploads/2023/05/payer-sentiment-study-2-720x405.jpg)
U.S. PAYER SENTIMENT STUDY 2
IRA, biosimilars, gene therapy & copay programs
![](https://www.sermo.com/wp-content/uploads/2023/02/sentiment-study-11-720x405.jpg)
Part 11
Social channels gain credibility with healthcare practitioners
![](https://www.sermo.com/wp-content/uploads/2022/12/hcp-part10-thumbnail-min-720x405.png)
Part 10
Insights for 2023 on HCP content habits and best practices
![](https://www.sermo.com/wp-content/uploads/2021/03/payer-sentiment-study-720x405.jpg)
U.S. Payer Sentiment Study 1
Challenges, opportunities & insights for 2023 & beyond
![](https://www.sermo.com/wp-content/uploads/2022/06/sentiment-study-9-600x338.jpg)
Part 9
Inflation, DEI, AI & patient choice in healthcare
![](https://www.sermo.com/wp-content/uploads/2022/02/blog-sentiment-study-8-720x405.jpg)
Part 8
What physicians REALLY want from medical device companies
![](https://www.sermo.com/wp-content/uploads/2021/10/blog-sentiment-study-7-720x405.jpg)
Part 7
Understand how COVID-19 is impacting the medical community
![](https://www.sermo.com/wp-content/uploads/2021/06/sentiment-study-6-720x405.jpg)
Part 6
Remote engagement & physician information sources
![](https://www.sermo.com/wp-content/uploads/2021/03/sentiment-study-5-720x405.jpg)
Part 5
Current & future remote engagement with pharma sales representatives
![](https://www.sermo.com/wp-content/uploads/2021/03/sentiment-study-4-1-720x405.jpg)
Part 4
Physician practice activity levels, telehealth adoption and challenges, and the future of pharma engagement
![](https://www.sermo.com/wp-content/uploads/2021/03/sentiment-study-3-720x405.jpg)
Part 3
Timing for physician bounce back to pre-pandemic patient activity levels & how this impacts HCP access
![](https://www.sermo.com/wp-content/uploads/2021/03/sentiment-study-2-720x405.jpg)
Part 2
Physician interactions with medical technology and pharmaceutical manufacturers
![](https://www.sermo.com/wp-content/uploads/2021/03/sentiment-study-1-720x405.jpg)
Part 1